Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Active, not recruiting · NCT04645212 · Registry updated 2026-02-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT] | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), choroidal neovascularization, eye disorder, macular degeneration, nervous system disorder, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, vision disorder, wet macular degeneration | Active, not recruiting | Not stated | 2026-02-10 | NCT04645212 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Adverum Biotechnologies, Inc. | 6 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||